Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9261996 | Best Practice & Research Clinical Rheumatology | 2005 | 20 Pages |
Abstract
RA patients and their friends and families incur the majority of costs associated with early RA. Many patients are not able to continue to work at the same level as they would have anticipated had they not developed RA. Later on, society bears an increased load, especially in patients with higher levels of disability; this results from major social care costs and interventions such as surgery. However, the evidence favouring expensive biological therapies, even in early RA, is likely to turn this analysis on its head in the near future.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
David L. (Professor of Clinical Rheumatology), Claire (Clinical Trials Co-ordinator), Gabrielle (Reader in Rheumatology),